« Back to Record
Lehmann-Che, J., Andre, F., Desmedt, C., Mazouni, C., Giacchetti, S., Turpin, E., Espié, M., Plassa, L.-F., Marty, M., Bertheau, P., Sotiriou, C., Piccart-Gebhart, M., Symmans, W. F., Pusztai, L., & de Thé, H. (2010). Cyclophosphamide dose intensification may circumvent anthracycline resistance of p53 mutant breast cancers. The oncologist, 15(3), 246-252. doi:10.1634/theoncologist.2009-0243
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/57808



